as 01-17-2025 4:00pm EST
Stocks
Jupiter Neurosciences Inc is a clinical stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a unique resveratrol platform product primarily targeting treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to most central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.
Founded: | 2015 | Country: | United States |
Employees: | N/A | City: | JUPITER |
Market Cap: | 281.4M | IPO Year: | 2024 |
Target Price: | N/A | AVG Volume (30 days): | 490.6K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.05 | EPS Growth: | N/A |
52 Week Low/High: | $3.86 - $19.51 | Next Earning Date: | 02-11-2025 |
Revenue: | N/A | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
JUNS Breaking Stock News: Dive into JUNS Ticker-Specific Updates for Smart Investing
GlobeNewswire
6 days ago
GlobeNewswire
a month ago
The information presented on this page, "JUNS JUPITER NEUROSCIENCES INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.